CB1 Capital Management Adds to Advisory Board
Adviser Focused on Cannabinoid-Based Wellness Strategies
PORT WASHINGTON, N.Y., March 20, 2018 (Newswire.com) - CB1 Capital Management LLC, the New York-based investment adviser that invests in the supply chain of cannabinoid-based solutions, products and therapies that address a wide range of unmet medical or physiological conditions or commercial use-cases, is pleased to announce the addition of Dr. Julie Holland to its advisory board.
Dr. Holland is a New York-based psychiatrist and psychopharmacologist, the author of the bestsellers Weekends at Bellevue and Moody Bitches, and the editor of The Pot Book: A Complete Guide to Cannabis. She also is a medical monitor for a clinical study examining the efficacy of using cannabis in the treatment of Post-Traumatic Stress Disorder in veterans.
Cannabis isn't about getting high; it's about getting well.
Todd Harrison, Founding Partner / Chief Investment Officer
“We’re honored to have Dr. Holland join our advisory board as we further our commitment to better understand the science that drives cannabinoid-based wellness solutions,” said Todd Harrison, founding partner and chief investment officer of CB1 Capital Management. “She brings a wealth of experience and valuable perspective as we pursue our investment strategy.”
The other members of the CB1 advisory board include:
Dave Charnick: subject-matter expert; founder, Kalyx Development Inc., Green Space Labs, NOBO Partners; and special advisor, Cannabis Benchmarks, a division of New Leaf Data Sciences.
Lorne Gertner: chairman of HG2 Capital Corp; CEO of Hill & Gertner Capital Group; co-founder, The Cronos Group; director, Emblem Corp.; co-founder and chairman of Tokyo Smoke; investment partner and director, Green Acre Capital; director, Hempco Food & Fiber.
Gary Johnson: 29th governor of New Mexico; two-time presidential candidate; founder, Big J Enterprises; former CEO of Cannabis Sativa Inc.
Dr. Ethan Russo: board-certified neurologist; psychopharmacology researcher; director of research and development, International Cannabis and Cannabinoid Institute (ICCI); former senior medical advisor, GW Pharmaceuticals; former medical director, PHYTECS.
About CB1 Capital Management LLC
Based in New York, CB1 Capital Management LLC is an investment adviser that invests in securities of companies in the cannabinoid-wellness space. Nothing contained in this release is intended as a solicitation to invest.
Contact:
info@cb1cap.com
636-378-4939
Source: CB1 Capital Management
Related Media
